This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The recent Board of Appeal decision in T 0670/20 considered whether patients in a clinical trial were under conditions of confidentiality. The question became whether the patients could be considered members of the public, and whether their participation in the clinical trial therefore constituted prior publicuse of the formulation.
What is it that makes a use “public” for purposes of the publicuse bar? Does it matter whether the person doing the using is a member of the public, as opposed to the inventor? Or does it matter whether the use is itself in public, as opposed to taking place in secret behind closed doors?
Kaijet highlights the narrowness of the pre-filing grace period (safe harbor) provision under the America Invents Act (AIA) and serves as a reminder that there are a number of patents that would have been valid under the pre-AIA patent system may no longer be valid under the current law. HyperDrive apparently embodies the claimed invention.
One of the most effective ways of obtaining the revocation is to prove “prior publicuse”. One of them is undoubtedly, “prior publicuse”, since unless the case is very evident, the EPO is not usually able to collect this type of evidence as a result of the search that it conducts for the state of the art during the grant procedure.
The Opponent, Avl List GmbH, challenged the patent's validity based on several grounds, including prior publicuse as evidenced by a user manual describing the invention. A more nuanced standard to the assessment of evidence for prior use? Both parties appealed the OD decision. Both parties appealed the OD decision.
This month the Federal Circuit decided a case involving whether the display of a flowering plant constitutes an invalidating prior publicuse. Attendees had no confidentiality obligations and “were not provided any gene or breeding information.” Under those facts, the Federal Circuit determined there was no prior publicuse.
In our AI-driven world, we might rephrase it as: If we share our secrets with an AI language model like ChatGPT, but the information remains unused, does it count as trade secret disclosure or public disclosure of an invention? Spoiler alert: sharing invention details with ChatGPT does not count as publicuse or on sale.
In our AI-driven world, we might rephrase it as: If we share our secrets with an AI language model like ChatGPT, but the information remains unused, does it count as trade secret disclosure or public disclosure of an invention? Spoiler alert: sharing invention details with ChatGPT does not count as publicuse or on sale.
The 1836 Patent Act added the caveat that no patent should issue on an invention previously “described in any printed publication.” A new petition asks the court to examine the phrase again and help define when a document crosses the publication threshold. 102(a)(1). Centripetal Networks, Inc. 869, 877 (Fed.
In our AI-driven world, we might rephrase it as: If we share our secrets with an AI language model like ChatGPT, but the information remains unused, does it count as trade secret disclosure or public disclosure of an invention? Spoiler alert: sharing invention details with ChatGPT does not count as publicuse or on sale.
The Opponent submitted evidence of alleged prior use in the form of the insulin injection pen ( GensuPen ). The Opponent argued that the claimed invention lacked novelty in view of the prior use of the GensuPen ( Article 54(2) EPC ). The Opposition Division (OD) found that the alleged prior use was not sufficiently proven.
Here, the Federal Circuit has affirmed that the claims are invalid based upon a pre-filing trade-show display of the ornamental plant — holding that the display counted as a “publicuse.” ” The inventors here used conventional plant breeding to create a new form of petunia (Calibrachoa). Microsoft Corp.,
9,186,208 on surgical devices for a procedure called endometrial ablation were anticipated under the publicuse bar of pre-AIA 35 U.S.C. § Minerva did not disclose the devices under any confidentiality obligations, despite the commercial nature of the event. § 102(b).
Another source of confusion is the divergent approaches of the UK courts and the EPO with respect to the test for the evidence standard in sufficiency and inventive step analysis. Plausibility demystified - a review of EPO case law before G 2/21 G 2/21: Is the technical effect embodied by the invention as originally disclosed?
the Supreme Court held that an inventor’s sale of an invention to a third party who is obligated to keep the inventionconfidential can create an on-sale bar under AIA §102(a). The issue at the heart of ALJ Cheney’s decision was whether the Leahy-Smith America Invents Act’s (AIA) amendments to the on-sale bar in 35 U.S.C.
This month the Federal Circuit decided a case involving whether the display of a flowering plant constitutes an invalidating prior publicuse. Attendees had no confidentiality obligations and “were not provided any gene or breeding information.” But in that prior case, Delano Farms Co. § 161.
the Supreme Court held that an inventor’s sale of an invention to a third party who is obligated to keep the inventionconfidential can create an on-sale bar under AIA §102(a). In its 2018 decision in Helsinn Healthcare S.A. Teva Pharmaceuticals USA, Inc. , ” 35 U.S.C. § § 102(b) (pre-AIA).
It’s the legal term for ‘thing that is exactly like my thing that was in the public before I made my thing.’ The term covers anything that was sold in public, used publicly, described in a magazine or similar publication, or already has a patent on file with the patent office.
However, if the Contractor fails to report any inventions to the contracting officer within two months of preparing the corresponding patent applications, the Contractor risks losing ownership of those inventions. The inventor of the invention and the corresponding contract number that the agreement was conceived under.
The USPTO begins with a review of the duties of candor and good faith, confidentiality, and export regulations. One notable example provided in the guidance states: “Even if the servers are located within the United States, certain activities related to the use of AI systems hosted by these servers by non-U.S.
The parties are currently engaged in supplemental expert discovery on Hospira and Pfizer’s on-sale bar and publicuse defenses, and the court has resolved two discovery disputes this year stemming from these issues. Non-Confidential Brief for Plaintiff-Appellant at 25, 35.) 9,643,997, which is directed to protein purification.
We organize all of the trending information in your field so you don't have to. Join 9,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content